Back to Back Issues Page
Argus II Retinal Prosthesis System Implanted in 4 Patients
March 22, 2016

Argus II Retinal Prosthesis System Implanted in 4 Patients

There are several different bionic eye and retinal implants that are being developed, researched and improved upon. What's exciting is that they continually provide better vision or expand to new patient populations with each new development. One such bionic eye, is called the Argus II.

It is a multi-system implant and eye wear that bypasses the damaged photoreceptor cells - rods and cones that are responsible for converting light - so that the brain can perceive images via the optic nerve.

Argus II Clinical Trial

While the Argus II is FDA approved for those with retinitis pigmentosa, the first four patients with advanced dry macular degeneration have received the implant and device. The restored vision is very basic and elementary yet it can make a big difference in one's ability to see light, low resolution images and the ability to get a general sense of one's surroundings.

“The system is well tolerated and we can restore some visual function in patients with advanced AMD … For us and the patients, this is a significant achievement,” stated Consultant Ophthalmologist & Vitreoretinal Surgeon at the Manchester Royal Eye Hospital and Professor of Ophthalmology and Retinal Regeneration at the University of Manchester, Paulo Stanga.

Eighty year old, Ray Flynn, who has total loss of his central vision due to advanced dry age-related macular degeneration was the first recipient of the Argus II for macular degeneration. Click on the link to watch a video of how the implant works and how it impacted his vision:

How the Argus II Retinal Prosthesis System Works 

Leslie Degner, RN, BSN

Better Health for Better Vision

Back to Back Issues Page